This paper is in the following e-collection/theme issue:

Non-randomized Protocols and Methods (ehealth) (571) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1421)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/42574, first published .
Health Status, Quality of Life, Psychosocial Well-being, and Wearables Data of Patients With Active Ulcerative Colitis Receiving Filgotinib Therapy (FilgoColitis Study): Protocol for a Real-world Observational Study

Health Status, Quality of Life, Psychosocial Well-being, and Wearables Data of Patients With Active Ulcerative Colitis Receiving Filgotinib Therapy (FilgoColitis Study): Protocol for a Real-world Observational Study

Health Status, Quality of Life, Psychosocial Well-being, and Wearables Data of Patients With Active Ulcerative Colitis Receiving Filgotinib Therapy (FilgoColitis Study): Protocol for a Real-world Observational Study

Authors of this article:

Sandra Plachta-Danielzik1 Author Orcid Image ;   Lena Grasskemper1 Author Orcid Image ;   Karen Schmidt1 Author Orcid Image ;   Stefan Schreiber2 Author Orcid Image ;   Bernd Bokemeyer3 Author Orcid Image
Article Authors Cited by (2) Tweetations (2) Metrics

Journals

  1. Wanzl J, Schnoy E, Bettenworth D. Neue Therapien bei chronisch entzündlicher Darmerkrankung: „nibs“, „mabs“ und „mods“. Die Gastroenterologie 2023;18(6):423 View
  2. Chen Z, Jiang P, Su D, Zhao Y, Zhang M. Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease. Cytokine & Growth Factor Reviews 2024;79:1 View